{"id":390394,"date":"2019-06-21T00:00:00","date_gmt":"2019-06-21T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/trsqon0007-2019-biopharma-renal-cell-carcinoma-treatment-sequencing-us-2019\/"},"modified":"2026-04-15T23:23:49","modified_gmt":"2026-04-15T23:23:49","slug":"trsqon0007-2019-biopharma-renal-cell-carcinoma-treatment-sequencing-us-2019","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/trsqon0007-2019-biopharma-renal-cell-carcinoma-treatment-sequencing-us-2019\/","title":{"rendered":"Renal Cell Carcinoma | Treatment Sequencing | US | 2019"},"content":{"rendered":"<p><strong>KEY BENEFITS AND USES<\/strong><\/p>\n<ul>\n<li>Pinpoint current drug positioning and uptake in one snapshot to facilitate forecasting.<\/li>\n<li>Drill down into physicians\u2019 treatment sequences and understand who to position against or how to defend share.<\/li>\n<li>Identify untapped treatment scenarios and key competitors to aid trial design.<\/li>\n<li>Evaluate unique disease-specific treatment patterns and dynamics to plan and manage sales and marketing resources and execute commercialization messages.<\/li>\n<li>Discover untapped populations to expand product share and drive strategic decisions.<\/li>\n<\/ul>\n<p><strong>QUESTIONS ANSWERED<\/strong><\/p>\n<p>\u2022 Where is my product positioned vs. competitors in the treatment journey?<\/p>\n<p>\u2022 What are physicians\u2019 most frequent treatment sequences\u2014who is<\/p>\n<p>benefiting and how can I defend my assets share and position?<\/p>\n<p>\u2022 What are the market-relevant treatment scenarios according to oncology<\/p>\n<p>experts?<\/p>\n<p>\u2022 Where are the untapped business opportunities that I can capitalize<\/p>\n<p>upon?<\/p>\n<p>\u2022 How can I optimize trial design and ensure a competitive edge for my<\/p>\n<p>pipeline asset?<\/p>\n<p><strong>GEOGRAPHIES<\/strong><\/p>\n<p>United States<\/p>\n<p><strong>PRIMARY MARKET RESEARCH<\/strong><\/p>\n<p>Survey of ~100 U.S. physicians<\/p>\n<p><strong>2019 COVERAGE<\/strong><\/p>\n<p>Colorectal Cancer (US)<\/p>\n<p>Multiple Myeloma (US)<\/p>\n<p>Non-Hodgkin&#8217;s Lymphoma and Chronic Lymphocytic Leukemia (US)<\/p>\n<p>Non-Small-Cell Lung Cancer (US)<\/p>\n<p>Ovarian Cancer (US)<\/p>\n<p>Prostate Cancer (US)<\/p>\n<p>Renal Cell Carcinoma (US)<\/p>\n<p><strong>KEY FEATURES<\/strong><\/p>\n<ul>\n<li>Market-relevant treatment scenarios and subpopulations from oncology experts<\/li>\n<li>Drug share and treatment rates mapped to treatment journey using physician survey data<\/li>\n<li>Physicians\u2019 most frequently selected treatment sequences<\/li>\n<li>Access to expert oncology analysts for bespoke support<\/li>\n<\/ul>\n<p><strong>PRODUCT DESCRIPTION<\/strong><\/p>\n<p>Treatment Sequencing provides disease-specific, sequential treatment<\/p>\n<p>patterns in market-relevant treatment scenarios and drug share mapped to<\/p>\n<p>treatment journey. The quantitative sequencing analysis illuminates drug<\/p>\n<p>positioning through primary market research-based insights from physicians<\/p>\n<p>and DRG oncology experts\u2019 assumptions.<\/p>\n","protected":false},"template":"","class_list":["post-390394","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-renal-cell-carcinoma","biopharma-geography-us","biopharma-date-931"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390394","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390394\/revisions"}],"predecessor-version":[{"id":393519,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/390394\/revisions\/393519"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=390394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}